Open AccessSevere edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase‐4 inhibitor
Author(s) -
Maita Hiroki,
Kobayashi Tadashi,
Akimoto Takashi,
Osawa Hiroshi,
Kato Hiroyuki
Publication year - 2022
Publication title -
journal of general and family medicine
Language(s) - English
Resource type - Journals
ISSN - 2189-7948
DOI - 10.1002/jgf2.502
Subject(s) - sitagliptin , blisters , medicine , edema , dipeptidyl peptidase 4 , dipeptidyl peptidase 4 inhibitor , adverse effect , diabetes mellitus , endocrinology , immunology , type 2 diabetes
Severe edema and blood blisters can occur as adverse events associated with sitagliptin. A history of dipeptidyl peptidase‐4 inhibitors should be considered when examining patients with edema and blood blisters of uncertain cause.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom